JP2016530303A5 - - Google Patents

Download PDF

Info

Publication number
JP2016530303A5
JP2016530303A5 JP2016540943A JP2016540943A JP2016530303A5 JP 2016530303 A5 JP2016530303 A5 JP 2016530303A5 JP 2016540943 A JP2016540943 A JP 2016540943A JP 2016540943 A JP2016540943 A JP 2016540943A JP 2016530303 A5 JP2016530303 A5 JP 2016530303A5
Authority
JP
Japan
Prior art keywords
compound
cells
combination
composition
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016540943A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016530303A (ja
JP6659546B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/055021 external-priority patent/WO2015038662A1/en
Publication of JP2016530303A publication Critical patent/JP2016530303A/ja
Publication of JP2016530303A5 publication Critical patent/JP2016530303A5/ja
Application granted granted Critical
Publication of JP6659546B2 publication Critical patent/JP6659546B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016540943A 2013-09-10 2014-09-10 生細胞内への分子の送達のための組成物および方法 Active JP6659546B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361876006P 2013-09-10 2013-09-10
US61/876,006 2013-09-10
PCT/US2014/055021 WO2015038662A1 (en) 2013-09-10 2014-09-10 Compositions and methods for the delivery of molecules into live cells

Publications (3)

Publication Number Publication Date
JP2016530303A JP2016530303A (ja) 2016-09-29
JP2016530303A5 true JP2016530303A5 (cg-RX-API-DMAC10.html) 2017-10-19
JP6659546B2 JP6659546B2 (ja) 2020-03-04

Family

ID=52666235

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016540943A Active JP6659546B2 (ja) 2013-09-10 2014-09-10 生細胞内への分子の送達のための組成物および方法

Country Status (7)

Country Link
US (2) US9662404B2 (cg-RX-API-DMAC10.html)
EP (1) EP3043811B1 (cg-RX-API-DMAC10.html)
JP (1) JP6659546B2 (cg-RX-API-DMAC10.html)
AU (1) AU2014318839B2 (cg-RX-API-DMAC10.html)
CA (1) CA2923664C (cg-RX-API-DMAC10.html)
ES (1) ES2794599T3 (cg-RX-API-DMAC10.html)
WO (1) WO2015038662A1 (cg-RX-API-DMAC10.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3149413C (en) * 2015-04-10 2025-07-08 Feldan Bio Inc. Polypeptide-based carrier agents to improve the transduction efficiency of polypeptide cargo to cytosol in target eukaryotic cells and their uses, methods, and related kits
FR3048698B1 (fr) 2016-03-11 2021-03-05 Univ Claude Bernard Lyon Inhibiteurs de l'interaction bcl2 l10 / recepteur ip3
US11629170B2 (en) 2016-10-12 2023-04-18 Feldan Bio Inc. Rationally-designed synthetic peptide shuttle agents for delivering polypeptide cargos from an extracellular space to the cytosol and/or nucleus of a target eukaryotic cell, uses thereof, methods and kits relating to same
AU2017341736B2 (en) * 2016-10-12 2022-09-08 Feldan Bio Inc. Rationally-designed synthetic peptide shuttle agents for delivering polypeptide cargos from an extracellular space to the cytosol and/or nucleus of a target eukaryotic cell, uses thereof, methods and kits relating to same
JP7068711B2 (ja) * 2017-03-22 2022-05-17 国立大学法人京都大学 細胞質送達ペプチド
WO2019036375A1 (en) 2017-08-14 2019-02-21 Sanford Burnham Prebys Medical Discovery Institute CARDIOGENIC MESODERMA TRAINING REGULATORS
US12029804B2 (en) 2018-11-02 2024-07-09 Soonchunhyang University Industry Academy Cooperation Foundation Peptide for promoting mucous membrane permeation and composition containing same
CN113423834A (zh) 2018-11-08 2021-09-21 加总生物公司 微核小体核心蛋白及其在核酸递送中的用途
KR102201154B1 (ko) * 2019-03-26 2021-01-12 가천대학교 산학협력단 폴리글루타메이트-TAT-Cre 융합 단백질의 제조방법
CA3040645A1 (en) 2019-04-18 2020-10-18 Feldan Bio Inc. Peptide-based non-proteinaceous cargo delivery
EP4136235A4 (en) 2020-04-13 2024-10-16 Summation Bio, Inc. MINI-NUCLEOSOME CORE PROETIN AND THEIR USE IN NUCLEIC ACID DELIVERY

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6258774B1 (en) * 1998-03-19 2001-07-10 University Of Medicine And Dentistry Of New Jersey Carrier for in vivo delivery of a therapeutic agent
EP1968643A2 (en) 2005-12-16 2008-09-17 Diatos Cell penetrating peptide conjugates for delivering of nucleic acids into a cell
AU2008329563A1 (en) * 2007-11-30 2009-06-04 Cytomatrix Pty Ltd Methods of inducing pluripotency involving Oct4 protein
WO2010059806A2 (en) * 2008-11-20 2010-05-27 Cedars-Sinai Medical Center Generation of induced pluripotent stem cells without the use of viral vectors
WO2010072228A1 (en) * 2008-12-22 2010-07-01 Xigen S.A. Novel transporter constructs and transporter cargo conjugate molecules
US20120128655A1 (en) * 2009-04-03 2012-05-24 The Mclean Hospital Corporation Induced pluripotent stem cells
CA3032186C (en) 2010-07-13 2022-04-26 Council on Postsecondary Education, State of Rhode Island and Providence Plantations Environmentally sensitive composition comprising a ph triggered peptide and uses thereof
WO2012090150A2 (en) 2010-12-27 2012-07-05 Compugen Ltd New cell-penetrating peptides and uses thereof

Similar Documents

Publication Publication Date Title
JP7317706B2 (ja) 核酸およびタンパク質ペイロード送達のための方法および組成物
JP2018512891A5 (cg-RX-API-DMAC10.html)
RU2012153218A (ru) Пептиды, проникающие в клетки, и их применения
JP7617603B2 (ja) R-スポンジン(rspo)サロゲート分子
EP2573109A3 (en) Peptide vaccines comprising Seq Id 101, 80 or 100 for cancers expressing tumor-associated antigens
JP2019531316A5 (cg-RX-API-DMAC10.html)
MX355074B (es) Inmunoterapia novedosa contra varios tumores incluidos el cancer gastrico y gastrointestinal.
UA110599C2 (uk) Пептид для імунотерапії пухлин, включаючи нейрональні пухлини та пухлини мозку
JP2016501829A5 (cg-RX-API-DMAC10.html)
RU2010147076A (ru) Аналоги инсулина специфичные к изоформам
JP2012528599A5 (cg-RX-API-DMAC10.html)
US20240368224A1 (en) Bicyclic peptidyl pan-ras inhibitors
US20130097717A1 (en) Compositions and methods for re-programming cells without genetic modification for treatment of cardiovascular diseases
JP2014527801A5 (cg-RX-API-DMAC10.html)
JP2011509093A5 (cg-RX-API-DMAC10.html)
WO2011135222A3 (fr) Utilisation de peptides comme transporteurs destines a l'internalisation de molecules d'interet dans des cellules cibles
MX2009007261A (es) Vacuna de peptido foxp3.
MX2010005816A (es) Epítopos de péptido de stat3.
WO2014057437A3 (fr) Procede de preparation de proteine c1q recombinante
WO2022235610A9 (en) Electrophysiological modification to suppress arrhythmias
EP3159354B1 (en) Novel synthetic peptide and use thereof
RU2008153051A (ru) Способ направленной доставки днк в опухолевые и стволовые клетки
ATE490266T1 (de) In zellen eindringende peptide als träger für moleküle
WO2009105780A3 (en) Mntf peptide compositions and methods of use
Boheler Pluripotency of human embryonic and induced pluripotent stem cells for cardiac and vascular regeneration